关注
Maarten Ooms
Maarten Ooms
未知所在单位机构
在 sckcen.be 的电子邮件经过验证
标题
引用次数
引用次数
年份
Bismuth-213 for targeted radionuclide therapy: from atom to bedside
S Ahenkorah, I Cassells, CM Deroose, T Cardinaels, AR Burgoyne, ...
Pharmaceutics 13 (5), 599, 2021
692021
Retention of [18F] fluoride on reversed phase HPLC columns
D Ory, J Van den Brande, T de Groot, K Serdons, M Bex, L Declercq, ...
Journal of Pharmaceutical and Biomedical Analysis 111, 209-214, 2015
602015
Therapeutic Efficacy of 213Bi-labeled sdAbs in a Preclinical Model of Ovarian Cancer
Y Dekempeneer, V Caveliers, M Ooms, D Maertens, M Gysemans, ...
Molecular Pharmaceutics 17 (9), 3553-3566, 2020
432020
Preclinical evaluation of [18F] JNJ42259152 as a PET tracer for PDE10A
S Celen, M Koole, M Ooms, M De Angelis, I Sannen, J Cornelis, J Alcazar, ...
Neuroimage 82, 13-22, 2013
412013
Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in vivo in R6/2 Huntington mice
M Ooms, R Rietjens, JR Rangarajan, K Vunckx, S Valdeolivas, F Maes, ...
Neurobiology of aging 35 (12), 2858-2869, 2014
362014
Synthesis and preclinical evaluation of [11C] MA-PB-1 for in vivo imaging of brain monoacylglycerol lipase (MAGL)
M Ahamed, B Attili, D van Veghel, M Ooms, P Berben, S Celen, M Koole, ...
European journal of medicinal chemistry 136, 104-113, 2017
262017
Production of Sm-153 with very high specific activity for targeted radionuclide therapy
M Van de Voorde, C Duchemin, R Heinke, L Lambert, E Chevallay, ...
Frontiers in Medicine 8, 675221, 2021
192021
3p-C-NETA: A versatile and effective chelator for development of Al18F-labeled and therapeutic radiopharmaceuticals
S Ahenkorah, E Murce, C Cawthorne, JP Ketchemen, CM Deroose, ...
Theranostics 12 (13), 5971, 2022
172022
Striatal phosphodiesterase 10A availability is altered secondary to chronic changes in dopamine neurotransmission
M Ooms, S Celen, R De Hoogt, I Lenaerts, J Liebregts, G Vanhoof, ...
EJNMMI radiopharmacy and chemistry 1, 1-17, 2017
172017
[18F] JNJ 42259152 binding to phosphodiesterase 10A, a key regulator of medium spiny neuron excitability, is altered in the presence of cyclic AMP
M Ooms, B Attili, S Celen, M Koole, A Verbruggen, K Van Laere, ...
Journal of Neurochemistry 139 (5), 897-906, 2016
172016
Transition-metal-free synthesis of pyridine derivatives by thermal cyclization of N-propargyl enamines
Y Chikayuki, T Miyashige, S Yonekawa, A Kirita, N Matsuo, H Teramoto, ...
Synthesis 52 (07), 1113-1121, 2020
162020
Synthesis and biological evaluation of carbon-11 and fluorine-18 labeled tracers for in vivo visualization of PDE10A
M Ooms, S Celen, M Koole, X Langlois, M Schmidt, M De Angelis, ...
Nuclear Medicine and Biology 41 (8), 695-704, 2014
162014
Radiolabeling of Human Serum Albumin With Terbium-161 Using Mild Conditions and Evaluation of in vivo Stability
I Cassells, S Ahenkorah, AR Burgoyne, M Van de Voorde, CM Deroose, ...
Frontiers in Medicine 8, 675122, 2021
152021
Bifunctional chelators for radiorhenium: Past, present and future outlook
DR Melis, AR Burgoyne, M Ooms, G Gasser
RSC Medicinal Chemistry 13 (3), 217-245, 2022
142022
Inorganic radiolabeled nanomaterials in cancer therapy: a review
TA Lemaître, AR Burgoyne, M Ooms, TN Parac-Vogt, T Cardinaels
ACS Applied Nano Materials 5 (7), 8680-8709, 2022
132022
Discovery, radiolabeling, and evaluation of subtype-selective inhibitors for positron emission tomography imaging of brain phosphodiesterase-4D
Y Wakabayashi, S Telu, RM Dick, M Fujita, M Ooms, CL Morse, JS Liow, ...
ACS chemical neuroscience 11 (9), 1311-1323, 2020
122020
Preclinical Evaluation of [155/161Tb]Tb-Crown-TATE—A Novel SPECT Imaging Theranostic Agent Targeting Neuroendocrine Tumours
L Wharton, SW McNeil, H Merkens, Z Yuan, M Van de Voorde, G Engudar, ...
Molecules 28 (7), 3155, 2023
62023
A simple and automated method for 161Tb purification and ICP-MS analysis of 161Tb
SW McNeil, M Van de Voorde, C Zhang, M Ooms, F Bénard, ...
EJNMMI Radiopharmacy and Chemistry 7 (1), 31, 2022
62022
Synthesis and preliminary biological evaluation of [11C]-MP10 and its regio-isomer as potential radioligands for positron emission tomography imaging of phosphodieasterase-10A …
M Ooms, S Celen, A Verbruggen, K Van Laere, G Bormans
European Journal Of Nuclear Medicine And Molecular Imaging 37, S206-S206, 2010
62010
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [153Sm]Sm-DOTA-TATE
K Vermeulen, M Van de Voorde, C Segers, A Coolkens, ...
Pharmaceutics 14 (12), 2566, 2022
52022
系统目前无法执行此操作,请稍后再试。
文章 1–20